In tg5XFAD mice, an Alzheimer’s disease model, RNS60 treatment suppress neuronal apoptosis, attenuate tau phosphorylation, inhibit glia activation, reduces Aβ plaques aggregation and protects memory [28]. This evidence concerns the gene MAPT and Alzheimer disease.